A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Honeywell Signs Agreements to Advance Digitalization of Healthcare Globally

Honeywell (Nasdaq: HON) announced today its commitment to developing technology-led solutions for the future of healthcare delivery. Building on its deep expertise in the hospital setting, Honeywell signed Memorandums of Understanding (MOUs) with two leading healthcare companies with further collaborations to potentially follow in the United States and around the world.

The agreements provide a framework to co-innovate error-prone processes and tasks, enhance the patient experience and improve operational agility through digitalization.

COVID-19 highlighted the need for bringing efficiencies in healthcare delivery. From developing sensors and switch solutions that enhance the performance and reliability of ventilators, to protecting frontline workers with personal protective equipment, Honeywell has made significant investments in helping the industry respond to the COVID-19 pandemic. With one of the broadest portfolios of products for the healthcare environment, Honeywell’s engineered solutions provide the quality, durability and value needed to help deliver safer, more effective healthcare.

“The past few years have presented a myriad of challenges for already-stretched health systems and we’re not out of the woods yet. Over the next few years, the healthcare industry is expected to face an even greater surge in demand coupled with more rigorous cost-control pressures,” said Robert Robinson, vice president and general manager, Honeywell Healthcare Solutions. “Honeywell is committed to helping the industry respond to these challenges. We envision a future where every patient has access to quality, secure and effective care and every caregiver has access to digital tools that make their jobs easier and more efficient. We’re prepared to play a critical role in delivering on this vision and shaping the future of healthcare.”

As part of its commitment to advancing the digitalization of healthcare, Honeywell signed MOUs with the University Hospital Brno, the second largest hospital in the Czech Republic, and Narayana Hrudayalaya Limited (Narayana Health), one of India’s foremost healthcare service providers, to facilitate their digitalization journeys. The strategic partnerships lay the groundwork for the co-development of advanced technologies to aid in the transformation of healthcare delivery.

The initial pilot with University Hospital Brno involves testing skin patches for real-time monitoring of patients’ vital functions and making the data available via mobile app. Looking ahead, Honeywell is in discussions to equip the Department of Internal Cardiology with its smart voice and touchscreen nurse call system as part of a comprehensive update of the hospital information system.

Honeywell and Narayana Health plan to work together on the introduction of new products, establish technology development centers, co-create joint capabilities in technology development and research and undertake the development of fire safety codecs that help ensure an end-to-end life safety system to make hospitals safer. As a technology partner, Honeywell plans to also help enhance and optimize Narayana Health’s digital processes and offer training to its employees.

The healthcare industry is continuously evolving to maintain environments where patients and staff feel safe. With its robust portfolio of healthcare technologies, Honeywell provides innovative solutions that drive better patient outcomes delivered in efficient, safe and secure environments for caregivers and the communities they serve.

Honeywell Safety and Productivity Solutions (SPS) provides products, software and connected solutions that improve productivity, workplace safety and asset performance for our customers across the globe. We deliver on this promise through industry-leading mobile devices, software, cloud technology and automation solutions, the broadest range of personal protective equipment and gas detection technology, and custom-engineered sensors, switches and controls. For more information, please visit: sps.honeywell.com.

Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

SourceHoneywell
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy